JP2010529125A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010529125A5 JP2010529125A5 JP2010511187A JP2010511187A JP2010529125A5 JP 2010529125 A5 JP2010529125 A5 JP 2010529125A5 JP 2010511187 A JP2010511187 A JP 2010511187A JP 2010511187 A JP2010511187 A JP 2010511187A JP 2010529125 A5 JP2010529125 A5 JP 2010529125A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- agent according
- administered
- proton pump
- pump inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 35
- 229940124597 therapeutic agent Drugs 0.000 claims 35
- 229940126409 proton pump inhibitor Drugs 0.000 claims 14
- 239000000612 proton pump inhibitor Substances 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 11
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims 10
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 claims 6
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 claims 6
- 229960004770 esomeprazole Drugs 0.000 claims 6
- SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical group C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 claims 6
- 229960003174 lansoprazole Drugs 0.000 claims 6
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 claims 6
- 229960000381 omeprazole Drugs 0.000 claims 6
- 229960005019 pantoprazole Drugs 0.000 claims 6
- 229960004157 rabeprazole Drugs 0.000 claims 6
- YREYEVIYCVEVJK-UHFFFAOYSA-N rabeprazole Chemical compound COCCCOC1=CC=NC(CS(=O)C=2NC3=CC=CC=C3N=2)=C1C YREYEVIYCVEVJK-UHFFFAOYSA-N 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 4
- XGVADZZDFADEOO-YDALLXLXSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-oxo-4h-thieno[3,2-b]pyridine-6-carboxamide;hydron;chloride Chemical compound Cl.N([C@@H]1C2CCN(CC2)C1)C(=O)C(C1=O)=CNC2=C1SC=C2 XGVADZZDFADEOO-YDALLXLXSA-N 0.000 claims 4
- 235000021152 breakfast Nutrition 0.000 claims 2
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- AFUWQWYPPZFWCO-LBPRGKRZSA-N n-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-oxo-4h-thieno[3,2-b]pyridine-6-carboxamide Chemical compound N([C@@H]1C2CCN(CC2)C1)C(=O)C(C1=O)=CNC2=C1SC=C2 AFUWQWYPPZFWCO-LBPRGKRZSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93353507P | 2007-06-07 | 2007-06-07 | |
| PCT/US2008/007038 WO2008153884A1 (en) | 2007-06-07 | 2008-06-04 | Compositions useful for treating gastroesophageal reflux disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010529125A JP2010529125A (ja) | 2010-08-26 |
| JP2010529125A5 true JP2010529125A5 (enExample) | 2011-07-07 |
Family
ID=39619385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010511187A Pending JP2010529125A (ja) | 2007-06-07 | 2008-06-04 | 胃食道逆流疾患の治療に有用な組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20090131471A1 (enExample) |
| EP (1) | EP2152263A1 (enExample) |
| JP (1) | JP2010529125A (enExample) |
| CN (1) | CN101868236A (enExample) |
| AU (1) | AU2008262438A1 (enExample) |
| CA (1) | CA2690581A1 (enExample) |
| RU (1) | RU2009149637A (enExample) |
| WO (1) | WO2008153884A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5692838B2 (ja) * | 2009-12-15 | 2015-04-01 | 公立大学法人横浜市立大学 | 感覚器障害モデル動物 |
| US20120225922A1 (en) * | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
| US20150164047A1 (en) * | 2013-11-07 | 2015-06-18 | Urban Pet Haus, LLC | Edible cat toy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2699794B2 (ja) * | 1992-03-12 | 1998-01-19 | 三菱化学株式会社 | チエノ〔３，２−ｂ〕ピリジン誘導体 |
| US6132768A (en) * | 1995-07-05 | 2000-10-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors |
| JP3927738B2 (ja) * | 1999-10-25 | 2007-06-13 | キヤノン株式会社 | 通信システム |
| TWI256314B (en) * | 2000-02-09 | 2006-06-11 | Mitsubishi Pharma Corp | Preventive-therapeutical medicament for gastroesophageal reflux disease |
| UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| KR20060118421A (ko) * | 2003-08-29 | 2006-11-23 | 다이노젠 파마세우티컬스, 인코포레이티드 | 위장 운동 장애의 치료에 유용한 조성물 |
-
2008
- 2008-06-04 CA CA2690581A patent/CA2690581A1/en not_active Abandoned
- 2008-06-04 AU AU2008262438A patent/AU2008262438A1/en not_active Abandoned
- 2008-06-04 CN CN200880101836A patent/CN101868236A/zh active Pending
- 2008-06-04 EP EP08768123A patent/EP2152263A1/en not_active Withdrawn
- 2008-06-04 WO PCT/US2008/007038 patent/WO2008153884A1/en not_active Ceased
- 2008-06-04 US US12/156,787 patent/US20090131471A1/en not_active Abandoned
- 2008-06-04 RU RU2009149637/15A patent/RU2009149637A/ru not_active Application Discontinuation
- 2008-06-04 JP JP2010511187A patent/JP2010529125A/ja active Pending
-
2010
- 2010-04-01 US US12/752,702 patent/US20100247584A1/en not_active Abandoned
-
2011
- 2011-07-19 US US13/185,796 patent/US20110275667A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535814A5 (enExample) | ||
| JP2007527914A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| NZ586751A (en) | Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function | |
| JP2010529118A5 (enExample) | ||
| JP2007519649A5 (enExample) | ||
| WO2008131056A3 (en) | Sustained release monoeximic formulations of opioid and nonopioid analgesics | |
| JP2006143751A5 (enExample) | ||
| JP2004538303A5 (enExample) | ||
| JP2009533356A5 (enExample) | ||
| JP2010059183A5 (enExample) | ||
| HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
| JP2009507838A5 (enExample) | ||
| RU2011108026A (ru) | Комбинированная терапия туберкулеза | |
| JP2008508279A5 (enExample) | ||
| JP2011502997A5 (enExample) | ||
| JP2008505857A5 (enExample) | ||
| JP2013509411A5 (enExample) | ||
| JP2014505107A5 (enExample) | ||
| JP2009215293A5 (enExample) | ||
| JP2012502103A5 (enExample) | ||
| NZ592615A (en) | Method for treating or preventing thrombosis using 150 mg b.i.d. of dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy | |
| JP2009513713A5 (enExample) | ||
| JP2009062388A5 (enExample) | ||
| HRP20191559T1 (hr) | Farmaceutski pripravci za liječenje infekcije bakterijom helicobacter pylori |